|
SciClone Gains China Rights to Zensun’s Heart Failure Drug
|
$5.00
|
|
|
BioDuro Opens Second China CRO Lab, This One in Shanghai
|
$5.00
|
|
|
RuiYi and Genor Enter License and Collaboration for Novel mAb
|
$5.00
|
|
|
Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing
|
$5.00
|
|
|
WuXi PharmaTech Reports Higher Q1; Analyzes Prospects for its Business
|
$5.00
|
|
|
RuiYi Selects CMC Biologics to Develop Cell Line for mAb
|
$5.00
|
|
|
Vectura and KingYork Form China Respiratory JV
|
$5.00
|
|
|
ScinoPharm and Coland to Develop Oncology Drugs for China
|
$5.00
|
|
|
Zhejiang Beta Pharma Forms JV with Amgen
|
$5.00
|
|
|
Hutchison Chi-Med in Partner Talks for Cancer Drug
|
$5.00
|
|
|
Zhejiang Huahai and Oncobiologics Sign Biosimilar Pact
|
$5.00
|
|
|
Teva's CEO Thinks China is a “Natural Fit”
|
$5.00
|
|
|
Leadman to Distribute IDS’s Diagnostic Products in China
|
$5.00
|
|
|
Sagent Pharma Pays $25 Million to Buy out China JV Partner
|
$5.00
|
|
|
Li Ka-Shing Donates $31 Million to Medical Research Institute at Oxford
|
$5.00
|
|
|
Zhejiang Huahai Raises $126 Million for New Production Facility
|
$5.00
|
|
|
3SBio Schedules Take-Private Vote for May 24
|
$5.00
|
|
|
China Budgets $48.6 Million to Monitor H7N9 Bird Flu
|
$5.00
|
|
|
OrbusNeich of Hong Kong Wins Patent Suit against Boston Scientific
|
$5.00
|
|
|
Ascletis In-Licenses China Rights to HIV Drug from Janssen
|
$5.00
|
|
|
Fosun, Chindex and PE Fund Buy Israeli Aesthetic Device Company
|
$5.00
|
|
|
China Researchers Clear Blocked Blood Vessels with Lasers
|
$5.00
|
|
|
Eisai Building Second Production Facility in Suzhou
|
$5.00
|
|
|
Takeda and Sanofi Strike Diabetes Drug Co-Promotion in China
|
$5.00
|
|
|
3SBio Ups its Take-Private Offer as Opposition Rises
|
$5.00
|
|
|
Hua Han Bio-Pharma and China National Biotec Announce JV
|
$5.00
|
|
|
WuXi PharmaTech VC Fund Participates in Syros Pharma's Initial Round
|
$5.00
|
|
|
Tasly Pharma Buys 100% of TaslyDiyi Pharma
|
$5.00
|
|
|
Zongyi Group Invests $8.6 Million in ContraFect, a US Biotech
|
$5.00
|
|
|
Wuhan Kindstar Announces Collaboration with Illumina
|
$5.00
|
|
|
Cipla Launches Shanghai CP Guojian’s Biosimilar in India
|
$5.00
|
|
|
Suzhou Ascepion and Debiopharm to Develop Cancer Drug for China
|
$5.00
|
|
|
Merck Opens $120 Million Packaging Plant in Hangzhou
|
$5.00
|
|
|
Injex Pharma Given China Approval for Needle-Free Delivery Device
|
$5.00
|
|
|
Thermo Fisher Buys Life Technologies; Aims to Grow in Asia
|
$5.00
|
|
|
Shenzhen Chipscreen Reports Phase II Success of Cancer Drug
|
$5.00
|
|
|
Furui Subsidiary Receives US Approval for Liver Test
|
$5.00
|
|
|
Eddingpharm and Chiesi Farmaceutici Form Asthma Drug JV
|
$5.00
|
|
|
Ascletis and Roche to Develop Hepatitis C Treatment for China
|
$5.00
|
|
|
Ascletis and Roche to Develop Hepatitis C Treatment for China
|
$5.00
|
|
|
China’s NCDS and PerkinElmer Set Up Biomarker Partnership
|
$5.00
|
|
|
US FDA Requests $4.7 Million for China Drug Maker Inspections
|
$5.00
|
|
|
Lilly Invests $100 Million in China Animal Healthcare Ltd.
|
$5.00
|
|
|
TRT Chinese Medicines Expects to IPO on ChiNext
|
$5.00
|
|
|
OriGene Pays $16 Million for Antibody Maker SDIX
|
$5.00
|
|
|
Eddingpharm to Distribute Breast Cancer Drug for GSK in China
|
$5.00
|
|
|
China’s SFDA Ready to Fast-Track Approvals of Peramivir, a Flu Treatment
|
$5.00
|
|
|
Jiangsu Hengrui In-Licenses China Rights to AMD mAb from X-Body
|
$5.00
|
|
|
Sanofi Pasteur Funds Xiamen University Research on Universal Flu Vaccine
|
$5.00
|
|
|
Hangzhou Nurotron Biotech Cuts Cost of Cochlear Implant
|
$5.00
|
|
|
Baxter Teams with China Officials to Bring Dialysis to Rural China
|
$5.00
|
|
|
New Bird Flu Strain Surfaces in China; Two Dead
|
$5.00
|
|
|
China NT Pharma and Sinopharm to Set Up Drug Distribution JV
|
$5.00
|
|
|
Sanofi Looking for China M&A to Increase Revenue
|
$5.00
|
|
|
Agenix to File for Clinical Trial of Hepatitis B Drug by June
|
$5.00
|
|
|
Life Technologies Gene Sequencer SFDA Approved for Diagnostic Use
|
$5.00
|
|
|
SK Biopharma Partners with China Companies on Novel CNS Drug
|
$5.00
|
|
|
China's MOH Issues New Essential Drug List with 520 Products
|
$5.00
|
|
|
Weihai Weigao to Distribute TriReme’s Cardiology Devices in China
|
$5.00
|
|
|
Cellular Biomedicine Starts China Trial of Liver Cancer Treatment
|
$5.00
|
|
|
GE Healthcare to Double China Production
|
$5.00
|
|
|
BGI and H3 Biomedicine to Sequence Pre-Clinical Cancer Models
|
$5.00
|
|
|
OriGene Raises $21.3 Million from China Investors
|
$5.00
|
|
|
Amoy Diagnostics Approved to Market IVD for Lung Cancer
|
$5.00
|
|
|
Hony Capital Backs Simcere’s Privatization Bid
|
$5.00
|
|
|
Roche May Make a Bid for Life Technologies
|
$5.00
|
|
|
Merck Serono and BMS Team Up to Offer Diabetes Drug to China
|
$5.00
|
|
|
BGI-Shenzhen Closes $118 Million Acquisition of Complete Genomics
|
$5.00
|
|
|
Antisense and TJAB Advance MS Drug
|
$5.00
|
|
|
Lilly Opens China IT Center to Facilitate Collaboration with Partners
|
$5.00
|
|
|
Taiwan Liposome’s Liver Cancer Drug Put on Fast Track in China
|
$5.00
|
|
|
Shanghai BravoBio Named BioSpectrum Emerging Company of the Year
|
$5.00
|
|
|
Pathwork Diagnostics Partners with Kindstar to Distribute Cancer IVD
|
$5.00
|
|
|
Sinovac Biotech’s Hand, Foot and Mouth Vaccine Succeeds in Phase III Trial
|
$5.00
|
|
|
Domain and Elite Team Up to Bring Life Science Products to China
|
$5.00
|
|
|
Shanghai Pharma Buys Stake in Chiatai Qingchunbao Pharma for $72 Million
|
$5.00
|
|
|
SFDA to Monitor Food Safety; Will Remain Part of MOH
|
$5.00
|
|
|
Catalent Pharma Expands in China with Two Deals
|
$5.00
|
|
|
Simcere Pharma Receives $503 Million Buyout Offer from Chairman
|
$5.00
|
|
|
WuXi PharmaTech Reports $500 Million in 2012 Revenues
|
$5.00
|
|
|
Sun Yat-sen University, Johns Hopkins Partner to Develop Medical Researchers
|
$5.00
|
|
|
Sinopharm to Raise $640 Million in Bond Offering; Is M&A the Goal?
|
$5.00
|
|
|
China National Biotec and Riboxx Set Up Research Collaboration
|
$5.00
|
|
|
WuXi PharmaTech Adds to OmniRat™ Antibody Technology Agreement
|
$5.00
|
|
|
Viva Biotech of Shanghai Forms Drug Discovery Partnership with Addex
|
$5.00
|
|
|
EntreMed Raises $10.7 Million from China-focused PE Funds
|
$5.00
|
|
|
Fosun Pharma Buys $22.4 Million of Saladax Stock
|
$5.00
|
|
|
China to Give SFDA Responsibility for Food as well as Drugs
|
$5.00
|
|
|
SFDA Proposes Further Reforms in China's Drug Approval Process
|
$5.00
|
|
|
Sinopharm Buys 57% of Winteam Pharma for $252 Million
|
$5.00
|
|
|
Polaris Group of San Diego to Build $50 Million Facility in Chengdu
|
$5.00
|
|
|
Fosun Pharma Forms China JV with Canada’s Atrium Innovation
|
$5.00
|
|
|
Mindray Medical Tops $1 Billion in 2012 Revenues
|
$5.00
|
|
|
OrbiMed Raising $500 Million for Asia Healthcare Fund
|
$5.00
|
|
|
Crystal Pharmatech and Particle Sciences Form CRO Partnership
|
$5.00
|
|
|
China Grand Pharma Forms JV with HuangShi Feiyun Pharma
|
$5.00
|
|
|
Pfizer Gains China Approval of Drug for Kinase-Specific Lung Cancer
|
$5.00
|
|
|
Reckitt Benckiser Buys Golong Medicine of Anhui, a TCM Maker
|
$5.00
|
|
|
Sihuan Granted SFDA Approval to Test New Diabetes Drug
|
$5.00
|
|
|
Beijing Double-Crane to Build $43 Million Shanghai Plant
|
$5.00
|
|
|
China’s SFDA Wants to Cut Number of Drug Distribution Companies by 10,000
|
$5.00
|
|
|
Regeneron and Bayer Start Phase III Trial of Macular Edema Drug in China
|
$5.00
|
|
|
Luye Pharma Completes US Phase II Trial of Cardiovascular TCM
|
$5.00
|
|
|
China Shenghuo Receives Go-Private Offer from Management
|
$5.00
|
|
|
Amgen will Use Partnerships and M&A to Enter China Market
|
$5.00
|
|
|
Shanshi Medical Device In-licenses Tensys Patient Monitoring System for China
|
$5.00
|
|
|
Celgene Gains SFDA Approval for Multiple Myeloma Treatment
|
$5.00
|
|
|
OxOnc to Partner with Pfizer on China Cancer Drug Trial
|
$5.00
|
|
|
Lee’s Pharma Subsidiary In-Licenses Dyax Drug for China Market
|
$5.00
|
|
|
3SBio Signs Official Go-Private Agreement
|
$5.00
|
|
|
Zheijang Hisun Nixes Celsion Deal after Drug Fails Trial
|
$5.00
|
|
|
Cardinal Health Has Acquired Six China Drug Distributors for $120 Million
|
$5.00
|
|
|
Neusoft to Buy Out its Medical Imaging JV Partner, Phillips
|
$5.00
|
|
|
Janssen Pharma Opens R&D Center in Shanghai
|
$5.00
|
|
|
Solasia to Start China Clinical Trial of Anti-Nausea Patch Product
|
$5.00
|
|
|
China’s Grandhope Biotech In-licenses Stem Cell Technology from Orthocell
|
$5.00
|
|
|
China's State Council Issues Bio-Industry Development Plan
|
$5.00
|
|
|
Luqa Pharma Launches Topical Scar Treatment in China
|
$5.00
|
|
|
Hainan Haiyao Pays $10 Million for SinoMab Stake
|
$5.00
|
|
|
MicroConstants China to Manage Clinical Research Center at #307 Hospital
|
$5.00
|
|
|
Lee’s Pharma Gains Negotiation Option for China Rights to Anticoagulant
|
$5.00
|
|
|
Aoxing Pharma Receives License for Narcotic Cough Treatment
|
$5.00
|
|
|
Xceleron and Crystal Pharmatech Team Up on Early-Stage CRO Services
|
$5.00
|
|
|
Huapont Pharma and Yes Biotech to Partner on Psoriasis Ointment
|
$5.00
|
|
|
Wilex Selects GeneDiagnostics to Distribute Cancer Test in China
|
$5.00
|
|
|
Simcere Sells Celgen Stake for $49 Million
|
$5.00
|
|
|
Sihuan Given SFDA Approval to Start Clinical Trial of Innovative Antibiotic
|
$5.00
|
|
|
Can-Fite Biopharma Shifts Drug Manufacturing to China
|
$5.00
|
|
|
China Proposes Fast-Track Approvals for Innovative Drugs
|
$5.00
|
|
|
Shenzhen Neptunus Bioengineering Files for US Test of TCM
|
$5.00
|
|
|
Stryker Buys Trauson, a China Orthopedic Company, for $764 Million
|
$5.00
|
|
|
Sanjiu Medical Pays $94 Million for China Medical Patch Maker
|
$5.00
|
|
|
Sihuan Pharma Gains OK for Opioid Inhibitor
|
$5.00
|
|
|
Nanjing Micro-Tech Announces “Significant” Investment from Actis
|
$5.00
|
|
|
China National Biotec’s $1.5 Billion IPO is Rumored Again
|
$5.00
|
|
|
Yunnan Walvax Buys 58% Stake in Vaccine-Maker Zerun Biotech
|
$5.00
|
|
|
Zhifei Biological Approved to Begin China Phase III Trial of TB Vaccine
|
$5.00
|
|
|
China GrandPharma In-Licenses Acetium Capsules from Finnish Company
|
$5.00
|
|
|
Guangdong Dahuanong Animal Health Buys Majority Stake in Competitor
|
$5.00
|
|
|
Joinn Labs of China Buys Bayer’s San Francisco-Area Campus
|
$5.00
|
|
|
China’s Latest Round of Price Cuts Hits Big Pharma Drugs
|
$5.00
|
|
|
EntreMed Files to Begin Clinical Trial of Cancer Drug in China
|
$5.00
|
|
|
Shanghai Fosun Pharma Buys Majority of Hunan Dongting for $93 Million
|
$5.00
|
|
|
China’s Cellular Biomedicine Group Announces Reverse Merger
|
$5.00
|
|
|
China’s BeBetter Medicine and PharmaEngine of Taiwan Form Cancer JV
|
$5.00
|
|
|
Tianjin KingYork and Innovata Announce $190 Million Asthma JV
|
$5.00
|
|
|
Sichuan Kelun Pharma Buys 12% of Lijun Pharma for $135 Million
|
$5.00
|
|
|
Naton Medical Forms Orthopedic Products JV in Malaysia
|
$5.00
|
|
|
Major China Biopharma Buys Bayer's Bay-Area Office/Lab Campus
|
$5.00
|
|
|
India to Open Drug Inspection Office in China
|
$5.00
|
|
|
HitGen and Viva Biotech Team Up to Provide Early-Stage CRO Services
|
$5.00
|
|
|
ShangPharma Accepts $9/ADS Go-Private Offer
|
$5.00
|
|
|
Techpool In-Licenses China Rights to Bone Cancer Drug from Roche
|
$5.00
|
|
|
AstraZeneca and Fudan Univ.to Collaborate on Cardiovascular Disease
|
$5.00
|
|
|
WuXi PharmaTech Teams Up with PRA to Form Clinical JV
|
$5.00
|
|
|
Omega Diagnostics Secures SFDA Approval for Food Allergy Test
|
$5.00
|
|
|
Sinopharm Lands $6.4 Billion in Support from CDB
|
$5.00
|
|
|
Mauna Kea Technologies Wins China Approval for Endoscopy Device
|
$5.00
|
|
|
Veridex, a J&J Company, Gains OK for Cancer IVD Test in China
|
$5.00
|
|
|
Jiangxi Boya Bio-Pharma to Buy Majority Stake in Haikang Biological
|
$5.00
|
|
|
China Leads Emerging Nations in Pharma M&A
Get instant access to this article for unlimited viewing and/or downloading for seven days.
|
$5.00
|
|
|
Fosun Pharma and Dalian Wanchun Announce Partnership
|
$5.00
|
|
|
Shanghai Institute to Collaborate with UK-based MRC Technology
|
$5.00
|
|
|
Roche Increases Focus on West China with New Chengdu Center
|
$5.00
|
|
|
Essex Woodlands Opens China Office to Fund Healthcare Deals
|
$5.00
|
|
|
Grupo Insud to Build $55 Million Veterinary Drug Facility
|
$5.00
|
|
|
Neusoft Medical Gains US Approval for 64-slice CT Scanner
|
$5.00
|
|
|
Covance’s Shanghai Lab Given GLP Certification by SFDA
|
$5.00
|
|
|
Edwards Lifesciences Wins SFDA OK for Heart Valve Replacement
|
$5.00
|
|
|
Guangzhou Pharma Absorbs Guangzhou Baiyunshan Pharma
|
$5.00
|
|
|
AstraZeneca Wins China Approval of Heart Drug
|
$5.00
|
|
|
TTY Biopharm Opens $100 Million Manufacturing Plant in Suzhou
|
$5.00
|
|
|
Qiagen Gains SFDA Approval for HPV Test Aimed at Rural Areas
|
$5.00
|
|
|
Chi-Med and Nestlé Form JV to Develop Chi-Med’s Lead Drug Candidate
|
$5.00
|
|
|
Crown Bioscience and Beijing Purunao Team Up to Develop Cancer Drugs
|
$5.00
|
|
|
Fosun Pharma and SIMM to Co-Develop Oncology Drug
|
$5.00
|
|
|
Stake in China Pharma R&D Center Co. Up for Sale
|
$5.00
|
|
|
Hua Medicine Advances Diabetes Treatment toward Trial
|
$5.00
|
|
|
iHuman Institute at Shanghai Tech to Study Cell Signaling
|
$5.00
|
|
|
Sihuan Pharma In-Licenses Two CCV Products from NeuroVive of Sweden
|
$5.00
|
|
|
Changshan Pharma and ConjuChem Form $3 Million Diabetes JV
|
$5.00
|
|
|
Henan Province Announces $40 Million VC Fund for Biologics
|
$5.00
|
|
|
Thermo Fisher Opens $20 Million Plant in China
|
$5.00
|
|
|
Innovent Biologics Raises $25 Million for Suzhou cGMP Facility
|
$5.00
|
|
|
Promega Opens Manufacturing Facility in Shanghai
|
$5.00
|
|
|
In China, Roche and Swiss Re Offer Insurance to Cover Biologic Drugs
|
$5.00
|
|
|
Hainan Haiyao Signs LOI for Stake in SinoMab Bioscience
|
$5.00
|
|
|
PerkinElmer Buys Haoyuan Biotech, a Diagnostics Company, for $38 Million
|
$5.00
|
|
|
India’s Orchid Chemicals and Pharma Quits its China Antibiotic JV
|
$5.00
|
|
|
Simcere Pharma Given OK to Start China Trial of Cancer Drug
|
$5.00
|
|
|
Sinopharm is in M&A Discussions with Foreign Pharmas
|
$5.00
|
|
|
Lundbeck Opens $7.6 Million Production Plant in Tianjin
|
$5.00
|
|
|
Akeso Biopharma, a China Antibody Company, Opens in Zhongshan
|
$5.00
|
|
|
Mindray Medical’s Q3 Financial Report Disappoints
|
$5.00
|
|
|
Zhongyuan Union to Set Up Stem Cell JV with Cell Therapy of the UK
|
$5.00
|
|
|
Vivo Ventures Leads $30 Million Funding of Shanghai Jingfeng Pharma
|
$5.00
|
|
|
Pioneer Pharma Completes $2.5 Million Investment in NovaBay
|
$5.00
|
|
|
Hutchison MediPharma Starts Clinical Trial of its Fourth Cancer Drug
|
$5.00
|
|
|
Innovent Constructing Biologic Facility in Suzhou
|
$5.00
|
|
|
Sihuan Pharma Announces SFDA Approval for Ulcer Drug
|
$5.00
|
|
|
SLG-Giant Pharm, a China CRO, to Run China Arm of US NIH Trial
|
$5.00
|
|
|
Charles River Labs Pays $27 Million for China Lab Animals Provider
|
$5.00
|
|
|
Fosun Pharma Drops in First Day of Hong Kong Trading
|
$5.00
|
|
|
DelMar and Guangxi Wuzhou Pharmas to Develop Cancer Drug
|
$5.00
|
|
|
Xiamen Innovax Launches World’s First Hepatitis E Vaccine
|
$5.00
|
|
|
US Medical Device Makers Target China’s 2nd and 3rd Tier Markets
|
$5.00
|
|
|
Kindstar Diagnostics to Offer BG Medicine’s Cardiac Test
|
$5.00
|
|
|
MicuRx Lands $9.6 Million to Fund China Trials of Antibiotic
|
$5.00
|
|
|
Fosun Prices Hong Kong IPO at Bottom of the Range
|
$5.00
|
|
|
AstraZeneca Signs $150 Million China Deal with Ironwood Pharma
|
$5.00
|
|
|
LifeTech Scientific to Market Broncus' Pulmonary Medical Devices in China
|
$5.00
|
|
|
Complete Genomics, Soon to Be a BGI Subsidiary, Wins Partial Victory in Illumina Patent Suit
|
$5.00
|
|
|
TNI BioTech Out-licenses Two Drugs to Hubei Qianjiang Pharma
|
$5.00
|
|
|
Legend Capital Invests in Innovative China Medical Device Companies
|
$5.00
|
|
|
Shenzhen Hepalink Signs Two Deals with ProMetic Life Sciences
|
$5.00
|
|
|
Half of Fosun Pharma’s Hong Kong IPO Will Fund Acquisitions
|
$5.00
|
|
|
Medtronic Makes another China Device Deal: LifeTech Scientific
|
$5.00
|
|
|
WuXi AppTec Opens China’s First cGMP Biologics Facility
|
$5.00
|
|
|
Shanghai Starts New Antibody Institute; Names US Researcher as Director
|
$5.00
|
|
|
Pharmaron, a Beijing CRO, Announces Partnership with AstraZeneca
|
$5.00
|
|
|
Fosun Pharma’s $600 Million Hong Kong IPO: Is it a Steal?
|
$5.00
|
|
|
TranS1 to Distribute Spinal Devices in China through Beijing Jiade Sunshine
|
$5.00
|
|
|
SFDA Releases 2011 Drug and Clinical Trial Approval Report
|
$5.00
|
|
|
Tianjin Pharma Says $25 Million Production Facility Nearly Complete
|
$5.00
|
|
|
LoneStar Heart Raises $20 Million in Round Led by Hong Kong PE Firm
|
$5.00
|
|
|
Cephasonics Signs China Medical Device Distribution Deal with Excelpoint
|
$5.00
|
|
|
RuiYi In-Licenses Cancer/Anti-Inflammatory mAb
|
$5.00
|
|
|
Fosun Pharma’s Hong Kong IPO Set to Raise $600 Million
|
$5.00
|
|
|
China Biotech May Soon Sell Vaccine to International Aid Groups
|
$5.00
|
|
|
Vital Therapies Secures $16 Million for Trial of Artificial Liver Device
|
$5.00
|
|
|
QPS Qualitix Opens China CRO Office
|
$5.00
|
|
|
MediStem and Superview to Develop Antibodies that Affect Stem Cells
|
$5.00
|
|
|
Sanofi Signs MOU for Rare Disease Collaboration with Sinopharm
|
$5.00
|
|
|
Neuralstem to Begin Clinical Trial of Stem Cell Product in Beijing
|
$5.00
|
|
|
China Nuokang Bio-Pharma Given Board OK to Go Private
|
$5.00
|
|
|
BayHelix and Elsevier Announce Four China Drug Development Awards
|
$5.00
|
|
|
Medicago Licenses China Rights for Flu Vaccine to Phillip Morris Co.
|
$5.00
|
|
|
BGI to Open Sequencing Facility in Singapore
|
$5.00
|
|
|
Novo Nordisk Opens Second R&D Center in Beijing
|
$5.00
|
|
|
Shanghai Kinetic Medical's Spinal Device OK’d in US
|
$5.00
|
|
|
China Announces Another Round of Drug Price Cuts
|
$5.00
|
|
|
NovaBay and Pioneer Expand China Partnership to Southeast Asia
|
$5.00
|
|
|
J&J to Establish Innovation Center in China
|
$5.00
|
|
|
China Cord Blood Lands $50 Million from Golden Meditech
|
$5.00
|
|
|
Two Drug Distributors, Alliance Boots and Nanjing Pharma, Ink $91 Million Deal
|
$5.00
|
|
|
BGI Shenzhen Buys Complete Genomics Inc. of the US for $117 Million
|
$5.00
|
|
|
Qiagen and Lepu Team Up to Provide Cardiac Diagnostic Tests in China
|
$5.00
|
|
|
Two Pharma JVs Start Operations in China: Hisun-Pfizer and Merck-Simcere
|
$5.00
|
|
|
3SBio Receives $337 Million Go-Private Offer
|
$5.00
|
|
|
China’s Generon Starts Clinical Trial of Biologic Anti-Inflammatory Drug
|
$5.00
|
|
|
WuXi AppTec and AstraZeneca Form Drug Development JV
|
$5.00
|
|
|
Triplex, a Diagnostics Company, Lands $50 Million from RRJ Capital
|
$5.00
|
|
|
China National Biotec Approved for $1.6 Billion Hong Kong IPO
|
$5.00
|
|
|
Dainippon Sumitomo Seeks SFDA Approval for Cancer Drug
|
$5.00
|
|
|
WuXi PharmaTech Licenses OMT’s OmniRat to Aid Biologic Drug Discovery
|
$5.00
|
|
|
China Medical Technologies Inc. Has "No Assets" according to Liquidators
|
$5.00
|
|
|
Elekta Wins $35 Million Radiation Therapy Contract from China's Military
|
$5.00
|
|
|
Life Technologies and Sino Biological Form Proteomics Partnership
|
$5.00
|
|
|
Fosun Pharma Lands $47 Million Loan from World Bank Unit
|
$5.00
|
|
|
New Beijing Facility for MicroConstants China Given GLP Cert
|
$5.00
|
|
|
CompanDX, a UK Biomarker Startup, Raises $6.1 Million from China
|
$5.00
|
|
|
WuXi PharmaTech Signs CMO Deal with TaiMed Biologics
|
$5.00
|
|
|
China to Grant India Greater Access to its Pharma Market
|
$5.00
|
|
|
New Essential Drug List Now Said to Include 700 Drugs
|
$5.00
|
|
|
Golden Meditech to Distribute Cord Blood Processing Device in China
|
$5.00
|
|
|
Tigermed and MSD China Sign LOI for Clinical Trial Services
|
$5.00
|
|
|
FortuneRock Given Go-Ahead to Begin China Trials of Long-Acting Interferon
|
$5.00
|
|
|
PRA , an International CRO, Opens Second Office in China
|
$5.00
|
|
|
Biostar Moves toward Launch of Topical Pain Relief Product
|
$5.00
|
|
|
Joincare Pharma to Build $157 Million Antibiotic Facility
|
$5.00
|
|
|
CNBG Institute Buys Vaccine Conjugate Technology from FinaBio
|
$5.00
|
|
|
Tigermed Completes $80 Million IPO on the ChiNext Exchange
|
$5.00
|
|
|
3SBio Files China IND for Anti-Autoimmune mAb from Apexigen
|
$5.00
|
|
|
Irish University Sets Up Collaboration with China Organizations
|
$5.00
|
|
|
Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen
|
$5.00
|
|
|
WuXi PharmaTech Reports 29% Rise in Q2 Revenues
|
$5.00
|
|
|
Cipla Focuses its China Investment, Emphasizes Biosimilars
|
$5.00
|
|
|
Medtronic in M&A Talks with China Medical Device Companies
|
$5.00
|
|
|
S*BIO of Singapore Sells Cancer Drug Rights to MEI Pharma
|
$5.00
|
|
|
Takeda Opens China Clinical Trial Center in Shanghai
|
$5.00
|
|
|
Biostar Pharma Says Gelatin Scandal Will Cut Q2 Revenues in Half
|
$5.00
|
|
|
Mindray Medical Beats Estimates with Strong Q2 Report
|
$5.00
|
|
|
PharmaEngine Acquires China Rights to Nanobiotix Cancer Product
|
$5.00
|
|
|
Barclays Upgrades Outlook on Companies in China Healthcare Sector
|
$5.00
|
|
|
Covidien Invests $45 Million into China Technology Center
|
$5.00
|
|
|
Luqa Pharma In-Licenses Scar Treatment from Stratapharma
|
$5.00
|
|
|
Kinex Pharma of the US Receives Investment from Hong Kong Investor
|
$5.00
|
|
|
Tigermed, a China Clinical Stage CRO, Schedules ChiNext IPO
|
$5.00
|
|
|
Roche to Hire 1,000 New Employees in China
|
$5.00
|
|
|
Transgene and Tasly JV Starts Operations with Four Transgene Molecules
|
$5.00
|
|
|
Officials: Chronic Disease Threatens China’s Healthcare System
|
$5.00
|
|
|
Suzhou Connect Biopharma Gains Rights to Arena’s Anti-Inflammatory Drugs
|
$5.00
|
|
|
SUMEC to Distribute Breast MRI Machines in China for Aurora
|
$5.00
|
|
|
Fenwal Holdings and Its China JV Bought by Fresenius of Germany
|
$5.00
|
|
|
WIBF and Refine Technology Collaborate on Vaccines
|
$5.00
|
|
|
TJAB Forms Drug Development JV with Antisense of Australia
|
$0.00
|
|
|
Chengdu Hoist Selling Animal Health Business
|
$5.00
|
|
|
China Health Resource Announces TCM for Migraine
|
$5.00
|
|
|
Shanghai Jia Fu Medical Apparatus Starts Stem Cell Clinical Trial
|
$5.00
|
|
|
Ironwood Pharma Files to Begin China Phase III Trial of Linaclotide
|
$5.00
|
|
|
Jinhe Biotech Stages a $78.6 Million Shenzhen IPO
|
$5.00
|
|
|
Lee’s Pharma Obtains China Rights to Therapeutic Peptide from RegeneRx
|
$5.00
|
|
|
Siegfried to Build API and Intermediates Plant in Nantong
|
$5.00
|
|
|
Oculus Announces SFDA Approval of Wound Healing Product
|
$5.00
|
|
|
Ascletis In-Licenses RNAi Drug for Liver Cancer from Alynlam
|
$5.00
|
|
|
HAO Capital and TCL Group to Set Up Medical Imaging JV
|
$5.00
|
|
|
Walvax Biotech Gains Majority Control of Fengmao Biotech
|
$5.00
|
|
|
SFDA Issues New Rules for Drug Excipients
|
$5.00
|
|
|
Karl Storz to Spend $31.5 Million on China Headquarters
|
$5.00
|
|
|
ShangPharma's Chairman Offers to Take the Company Private
|
$5.00
|
|
|
Beijing Starts Zero-Markup Policy on Drugs from Local Hospital
|
$5.00
|
|
|
SEC Halts Trading in China Medical’s Stock for Two Weeks
|
$5.00
|
|
|
ScinoPharm Building $37.6 Million Cancer Drug CMO in Tainan
|
$5.00
|
|
|
China Earmarks $11.8 Billion for Drug Innovation in 2016-2020 Five-Year Plan
|
$5.00
|
|
|
3SBio Given SFDA Permission for Phase III Trial of Anti-Rejection Drug
|
$5.00
|
|
|
PharmaNet/i3 Named Distinguished Partner by US-China Anti-Cancer Group
|
$5.00
|
|
|
China Pharmaceutical Group Pays $1.2 Billion for Robust Sun Holdings
|
$5.00
|
|
|
Sinopharm, Fosun, Meheco Join to Form $157 Million PE Fund
|
$5.00
|
|
|
Cardinal Health Buys Zhejiang Province Drug Distributor
|
$5.00
|
|
|
Zhejiang Medicine In-Licenses Novel Antibiotic from TaiGen
|
$5.00
|
|
|
Gentris of the US to Partner on Genomic Biomarkers with SIPM
|
$5.00
|
|
|
China Medical Technologies Faces Bankruptcy Petition from Bondholders
|
$5.00
|
|
|
Xiamen Innovax Biotech to Launch Hepatitis E Vaccine in China
|
$5.00
|
|
|
NeoStem Divests its 51% Stake in Suzhou Erye Pharma
|
$5.00
|
|
|
China’s Ascepion Out-licenses Cancer Drug Candidate to Debiopharm
|
$5.00
|
|
|
Quintiles to Spend $14 Million on China Headquarters and Central Lab
|
$5.00
|
|
|
Humanwell Healthcare Buys China Distributor of Roche Diagnostic Tests
|
$5.00
|
|
|
Shanghai Kinetic Medical Debuts on ChiNext Exchange
|
$5.00
|
|
|
GE Healthcare and BGI Team Up to Develop Stem Cell-based Assays
|
$5.00
|
|
|
Biostar Makes a Deal for New Topical Skin Disease Treatment
|
$5.00
|
|
|
Lilly Invests $20 Million in Novast Labs of China
|
$5.00
|
|
|
Suzhou Pharma Opens US Corporate Office
|
$5.00
|
|
|
Sinopharm to Float $1.3 Billion in Bonds
|
$5.00
|
|
|
Zhifei Biological Expands Vaccine Partnership with Merck
|
$5.00
|
|
|
Hutchison MediPharma Releases Phase I Data on Two Cancer Molecules
|
$5.00
|
|
|
Mindray Buys Majority Stake in China Orthopedic Implant Maker
|
$5.00
|
|
|
ShangPharma and Lilly Celebrate Ten Years of China Partnership
|
$5.00
|
|
|
India Unhappy about China’s Dominance in Antibiotic APIs
|
$5.00
|
|
|
Four Companies Join Forces to Form Pan-Asia Pacific Clincial CRO
|
$5.00
|
|
|
Former WuXi PharmaTech Employee Convicted for IP Theft
|
$5.00
|
|
|
Roche Diagnostics to Invest $310 Million in China
|
$5.00
|
|
|
GenScript Completes $40 Million R&D Center in Nanjing
|
$5.00
|
|
|
Boehringer Ingelheim Building $69 Million Plant in China Medical City
|
$5.00
|
|
|
Lilly Officially Opens Diabetes R&D Facility in Shanghai
|
$5.00
|
|
|
China’s State Council Reiterates Support for Biotechnology
|
$5.00
|
|
|
Sihuan Pharma Passes Inspection for New GI Drug
|
$5.00
|
|
|
Dongcheng Biochemicals Stages $110 Million IPO in Shenzhen
|
$5.00
|
|
|
Sanofi to Start China Clinical Trial of Cancer Drug In-licensed from SIBS
|
$5.00
|
|
|
China Research Team Develops TB/HIV Combination Vaccine
|
$5.00
|
|
|
Shanghai Pharma Faces Media Charges of Accounting Fraud
|
$5.00
|
|
|
China Tops the US – in Drug Reps
|
$5.00
|
|
|
Hisun Pharma to Invest $162 Million into its JV with Pfizer
|
$5.00
|
|
|
Xiangxue Pharma Gains China Rights to Kinex’s Glioma Drug
|
$5.00
|
|
|
ASLAN Pharma In-Licenses Rheumatoid Arthritis Treatment from Almirall
|
$5.00
|
|
|
Ventac Partners In-licenses Diabetes Treatments from Guangzhou Institute
|
$5.00
|
|
|
China National Biotech to Raise $1.6 Billion in Hong Kong IPO
|
$5.00
|
|
|
J&J in the Hunt for China Pharma Acquisitions
|
$5.00
|
|
|
Baxter Gains SFDA Approval for Recombinant Hemophilia Treatment
|
$5.00
|
|
|
Novozymes Opens Hyaluronic Acid Plant in Tianjin
|
$5.00
|
|
|
BMS Ups Investment in China R&D and Manufacturing
|
$5.00
|
|
|
Hisun Pharma to Supply Celsion’s Proprietary Cancer Drug
|
$5.00
|
|
|
IPO of Ningbo David Medical Device Greeted Warmly
|
$5.00
|
|
|
New China-Australia Research Center to Study TCM
|
$5.00
|
|
|
Conba Pharma Plans $148 Million Private Placement
|
$5.00
|
|
|
Mindray Acquires Controlling Stake in Optcla Medical Instrument
|
$5.00
|
|
|
Shanghai Generon Initiates a Phase II Trial for Breast Cancer in the US
|
$5.00
|
|
|
Enzon and Hisun Announce Strategic Alliance for PEGylation Technology in China
|
$5.00
|
|
|
Zhejiang Huahai and Breckenridge Sign Agreement for Generic HIV Drug
|
$5.00
|
|
|
First Medical Device Acquisition in China for Johnson & Johnson
|
$5.00
|
|
|
Conba Pharmaceutical Licenses Drug from Evotec for $95M Plus Royalties
|
$5.00
|
|
|
China Healthcare Budget Grows 20% in 2012
|
$5.00
|
|
|
Watson Pharma Buys Actavis in a Marriage of Generic Drugmakers
|
$5.00
|
|
|
Renhe Pharmacy Pays $46 Million for Two Pharma Acquisitions
|
$5.00
|
|
|
SK Pharm and Hanmi Pharm Will Bring Epilepsy Treatment to China
|
$5.00
|
|
|
Origin Agritech Sets Up Research Institute with Henan Agricultural University
|
$5.00
|
|
|
S*Bio Out-licenses Myelofibrosis Treatment to Cell Therapeutics
|
$5.00
|
|
|
Daiichi Sankyo Buys Shanghai Xinshengyuan Pharma
|
$5.00
|
|
|
TCM Treatment for Angina Approved for Use in Europe
|
$5.00
|
|
|
Luqa Pharma Out-licenses AfMET Rights for AntiFungal; Keeps China Rights
|
$5.00
|
|
|
Research Tool Maker Fluidigm Opens China Office
|
$5.00
|
|
|
Fidelity Targets Healthcare for Half of New $250 Million China Fund
|
$5.00
|
|
|
China Cord Blood Announces $65 Million Investment from KKR
|
$5.00
|
|
|
ThermoGenesis Gains SFDA Approval for Stem Cell Processing Device
|
$5.00
|
|
|
China Cord Blood Co. to Build Stem Cell Facility in Chongqing
|
$5.00
|
|
|
Fosun Pharma Given OK for Hong Kong IPO
|
$5.00
|
|
|
Lotus Pharma Runs Out of Cash
|
$5.00
|
|
|
Lee's Pharma In-Licenses GI-Protective Aspirin
|
$5.00
|
|
|
Hainan Haiyao Uses Knowshine to Develop Antibiotic Intermediate
|
$5.00
|
|
|
Zhejiang Hisun Pharma Files for US Approval to Start Clinical Trial of Statin
|
$5.00
|
|
|
Henan Taloph Raises $63.4 Million to Fund Projects
|
$5.00
|
|
|
Barclays Remains Negative on Most China Pharma Stocks Near-Term
|
$5.00
|
|
|
PhytoCeutica of the US to Advance Clinical Trials of TCM for Cancer
|
$5.00
|
|
|
Agenix to File for China Clinical Trials of Hepatitis Treatment
|
$5.00
|
|
|
GE Healthcare Targets China's Rural Markets with New Machines
|
$5.00
|
|
|
Bayer Extends and Expands Partnership with Tsinghua University
|
$5.00
|
|
|
Hubei Minkang Pharma to Gain Stake in Hubei Merryclin Pharma
|
$5.00
|
|
|
Roche Cuts the Price of Cancer Drugs in India – Under Pressure?
|
$5.00
|
|
|
Novasep Opens New Shanghai Facility
|
$5.00
|
|
|
Lee’s Pharma to Obtain China Rights for 3 Drugs from Regenerex
|
$5.00
|
|
|
GSK and Hanmi Pharma of Korea to Develop Drugs for China
|
$5.00
|
|
|
Chongqing Huapont to Raise $146 Million in Private Placement
|
$5.00
|
|
|
Fosun Purchases Another $35 Million of Simcere’s Stock
|
$5.00
|
|
|
Anaphore of San Diego Buys RuiYi, a Shanghai Drug Developer
|
$5.00
|
|
|
Qiagen to Partner with Shanghai Jiao Tong University Lab
|
$5.00
|
|
|
Lilly Wants to Double China Revenues; Seeks Distribution Partners
|
$5.00
|
|
|
CSPC Pharma Developing Patented Drugs
|
$5.00
|
|
|
Sihuan Pharma Doubled its Revenue in 2011
|
$5.00
|
|
|
Zhejiang Hisoar Given Japanese Approval for Antibiotic
|
$5.00
|
|
|
Beijing Closes Pharmacies in Two Hospitals
|
$5.00
|
|
|
Hisun Pharma Diversifies into Animal Health with New Partnership
|
$5.00
|
|
|
China’s Pressure on Drug Prices Hurts Outlook for Pharma
|
$5.00
|
|
|
InflammaGen Begins Clinical Trial of Treatment for Multi-Organ Failure
|
$5.00
|
|
|
Bayer Seeks $3.3 Billion of China Revenues by 2015
|
$5.00
|
|
|
Boehringer Ingelheim Plans Shanghai Animal Vaccine R&D Center
|
$5.00
|
|
|
OriGene Buys Zhongshan Golden Bridge Biotechnology
|
$5.00
|
|
|
Sihuan Pharma Files IND for New Anti-Hypertensive Drug
|
$5.00
|
|
|
China to Set Up Global Clinical Trial Center in Tianjin
|
$5.00
|
|
|
China Ups Science Budget for 2012
|
$5.00
|
|
|
3SBio and DaVita Announce $20 Million Dialysis JV for China
|
$5.00
|
|
|
Qiagen and KingMed to Offer HPV Test in China
|
$5.00
|
|
|
For Roche, China Is Necessary
|
$5.00
|
|
|
Jiangxi Boya Bio-Pharma IPOs on ChiNext Exchange
|
$5.00
|
|
|
Aslan Pharma Selects PharmaNet/i3 as Clinical Trial Partner
|
$5.00
|
|
|
EntreMed Opens China Office
|
$5.00
|
|
|
Abcam Buys Epitomics for $170 Million
|
$5.00
|
|
|
Shanghai Duyiwei Biotech Strikes mAb Deal with Apexigen
|
$5.00
|
|
|
Wuhan Kindstar Diagnostics Raises $20 Million for Testing Services
|
$5.00
|
|
|
GlaxoSmithKline Adopts Multi-Faceted Strategy for China
|
$5.00
|
|
|
MBK Partners Sells Luye Pharma Stake to Fellow PE Funds
|
$5.00
|
|
|
Yiling Pharma to Spend $22 Million on Three Drug Collaborations
|
$5.00
|
|
|
C3 Jian, a US Dental Company with China Connections, Raises $30 Million
|
$5.00
|
|
|
Cumberland Pharma Out-licenses Products to Harbin Gloria
|
$5.00
|
|
|
Bicon Pharma Lands $250 Million in PE Capital from PAG Asia
|
$5.00
|
|
|
Shanghai Pharma and Guangdong CDC to Research Vaccine Distribution
|
$5.00
|
|
|
Tibet Pharma Plans to End Short Stint as Public Company
|
$5.00
|
|
|
Newsummit Biopharma Files for $80 Million NYSE IPO
|
$5.00
|
|
|
Access Pharma Gains SFDA Approval for Oral Mucositis Treatment
|
$5.00
|
|
|
SFDA Approves Dynex Tech’s ELISA Analyzer
|
$5.00
|
|
|
China Raises Basic Healthcare Subsidy by 80%
|
$5.00
|
|
|
Pfizer Seeks More M&A to Expand China Generic Drug Offerings
|
$5.00
|
|
|
Hutchison MediPharma Starts Phase I Trial of Fourth Cancer Molecule
|
$5.00
|
|
|
Fosun Pharma Invests in Korean IVD Company
|
$5.00
|
|
|
BGI Collaborates with Big Pharma on Asia’s Most Common Cancers
|
$5.00
|
|
|
Pfizer and Zhejiang Hisun to Invest $545 Million in Generic Drug JV
|
$5.00
|
|
|
Asymchem Opens Large-Scale CMO Facility in Jilin Province
|
$5.00
|
|
|
Tianyin Pharma Builds Larger, cGMP-Compliant Facility
|
$5.00
|
|
|
Beijing Leadman Biochemistry Completes ChiNext IPO
|
$5.00
|
|
|
BioDuro Collaborates with Dow to Develop Crop Protection Products
|
$5.00
|
|
|
China Will Greatly Expand Essential Drug List
|
$5.00
|
|
|
BGI Opens European Genome Center in Copenhagen
|
$5.00
|
|
|
GSK Devotes Unit to Traditional Chinese Medicine R&D
|
$5.00
|
|
|
Zhejiang Medicine Drops Price on Private Placement
|
$5.00
|
|
|
Changchun BCHT Biotech Acquires Flu Vaccine Technology
|
$5.00
|
|
|
Shanghai Pharma to Spend $80 Million on North China Expansion
|
$5.00
|
|
|
Takeda Sets Up China Division to Supervise Clinical Trials
|
$5.00
|
|
|
Once Again, Fosun Pharma Plans Hong Kong IPO
|
$5.00
|
|
|
Nanjing Pharma’s Weak Financials Spark Takeover Talk
|
$5.00
|
|
|
Shanghai Biochip Signs MOU with GeneNews of Canada
|
$5.00
|
|
|
Shanghai Pharma Acquires Second API Maker This Year
|
$5.00
|
|
|
Steve Yang: AstraZeneca in China Wants to Transform Pharma R&D Models
|
$5.00
|
|
|
Cardinal Health Plans $90 Million in China Acquisitions
|
$5.00
|
|
|
AstraZeneca Pairs 7,300 Job Cuts with China Spending
|
$5.00
|
|
|
Tasly and SemBioSys Report Progress on their China JV
|
$5.00
|
|
|
Frontage Labs Completes US Phase I Trial for China TCM Company
|
$5.00
|
|
|
Beijing FDA Speeds Up its Fast-Track Review
|
$5.00
|
|
|
Transgene Starts Two New China Ventures
|
$5.00
|
|
|
Seven Young China Scientists Given $650,000 Howard Hughes Awards
|
$5.00
|
|
|
Syneron Announces SFDA Approval for Five Aesthetic Machines
|
$5.00
|
|
|
EntreMed Raises $10 Million from China-Connected Investors
|
$5.00
|
|
|
Sanjiu Pharma to Bid up to $110 Million for Shunfeng Pharma
|
$5.00
|
|
|
Jiangsu Kanion Out-licenses 3 Molecules to NewGen Therapeutics
|
$5.00
|
|
|
ShangPharma Achieves First Milestone in Hengrui Biologics Partnership
|
$5.00
|
|
|
Quintiles Opens New Support Center for China Clinical Trials
|
$5.00
|
|
|
Novartis Announces China Launch for Lucentis and Galvus
|
$5.00
|
|
|
Xiamen Innovax Biotech Gains Approval for Hepatitis E Vaccine
|
$5.00
|
|
|
Xizang Haisco Pharma Completes $127 Million IPO
|
$5.00
|
|
|
Da An Gene and Life Technologies Form JV
|
$5.00
|
|
|
NovaBay® Chooses Pioneer to Market NeutroPhase in China
|
$5.00
|
|
|
Hengrui and Crown Bioscience Announce Antibody Partnership
|
$5.00
|
|
|
Amerigen Pharma Announces Two China-US Deals
|
$5.00
|
|
|
Aeras and CNBG Partner on TB Vaccine
|
$5.00
|
|
|
Shanghai Pharma Subsidiary Buys 51% of Jinhe Biotech
|
$5.00
|
|
|
Mindray Climbs on Improved 2011 Revenues
|
$5.00
|
|
|
China Kanghui Granted FDA Approval for Two Joint Replacements
|
$5.00
|
|
|
AstraZeneca Wants to Build its Portfolio of Generic Drugs in China
|
$5.00
|
|
|
Darren Ji Steps Down as PharmaLegacy CEO
|
$5.00
|
|
|
Ascletis Lands $1.6 Million R&D Grant from Hangzhou Park
|
$5.00
|
|
|
ProteoTech and GSK (China) Collaborate on Parkinson’s Drug Candidate
|
$5.00
|
|
|
Vivo Ventures Closes $375 Million US-China Life Science Fund
|
$5.00
|
|
|
China Supports Foreign Direct Investment in Biotechnology
|
$5.00
|
|
|
Harbin Pharma Trades $870 Million of Stock for Assets from Parent
|
$5.00
|
|
|
China Health Resource, a TCM Maker, Ready to Start M&A Hunt
|
$5.00
|
|
|
Yunnan Baiyao Opens New Production Facility
|
$5.00
|
|
|
BioTime Options Cell Lines from USCN Life Science China
|
$5.00
|
|
|
Frontage Labs Opens Clinical-Stage CRO in Jilin Hospital
|
$5.00
|
|
|
Beijing Double-Crane Buys Transfusion Maker Huali
|
$5.00
|
|
|
Sanjiu Expected to Acquire Shunfeng Pharma through Auction
|
$5.00
|
|
|
ForteBio Acquired by Pall Corporation
|
$5.00
|
|
|
Hutchison MediPharma Inks $140 Million Cancer Deal with AstraZeneca
|
$5.00
|
|
|
Hengrui Gains FDA Approval for Cancer Drug
|
$5.00
|
|
|
Hua Medicine In-licenses Diabetes Drug Candidate from Roche
|
$5.00
|
|
|
Beijing SL Pharma Forms US-based Diabetes JV
|
$5.00
|
|
|
DSM Sinochem JV Building Second China Anti-Infective Facility
|
$5.00
|
|
|
China Sky One Partners Up to Form New Stem Cell Company
|
$5.00
|
|
|
Jilin Aodong Defers Investment in Vital Therapies
|
$5.00
|
|
|
Boehringer Ingelheim Sets $91 Million Shanghai Expansion
|
$5.00
|
|
|
Sihuan Pharma Building $110 Million Facility in Beijing
|
$5.00
|
|
|
Quintiles, a Clinical-Stage CRO, will Double China Headcount
|
$5.00
|
|
|
China Will Regulate TCM Products to Improve Their Purity
|
$5.00
|
|
|
Pfizer's Dual R&D Strategy for China
|
$5.00
|
|
|
ICON Builds China Presence by Acquiring BeijingWits, a Clinical CRO
|
$5.00
|
|
|
Mindray Medical Invests in Healthcare IT Company
|
$5.00
|
|
|
Beijing SL Pharma Buys Stake in Forwell Biopharm
|
$5.00
|
|
|
AstraZeneca Buys China Generic Drug Firm; Announces US Layoffs
|
$5.00
|
|
|
Conba Buys 84% of Yunnan Xiogye Pharma
|
$5.00
|
|
|
Aoxing Pharma Secures $3.2 Million from Bank Loan
|
$5.00
|
|
|
Merck Will Build Beijing R&D Center; Invest $1.5 Billion in China
|
$5.00
|
|
|
Foci Pharma to IPO in Shenzhen
|
$5.00
|
|
|
Taiantang Pharma Pays $21.4 Million for Stake in TCM Company
|
$5.00
|
|
|
LDR Given China Approval for Two Medical Devices
|
$5.00
|
|
|
Haibin Pharma Announces European Approval for Bulk Antibiotic
|
$5.00
|
|
|
WHO Certification a Shot-in-the-Arm for China Vaccine Makers
|
$5.00
|
|
|
PRC Increases Goals of Healthcare Reform
|
$5.00
|
|
|
Ascletis Nominated for Financing Deal of the Year
|
$5.00
|
|
|
Sihuan Bioengineering Sues Vitapharm to Unwind Deal
|
$5.00
|
|
|
Regeneron/Bayer Start China Trial of Wet AMD Drug
|
$5.00
|
|
|
Zhejiang Huahai Pharma to Raise $204 Million
|
$5.00
|
|
|
Fosun Pharma to Float up to $470 Million in Bonds
|
$5.00
|
|
|
Kunming and ZBD to Collaborate on TCM Injection
|
$5.00
|
|
|
A Second Life for Bayer’s Diabetes Drug in China
|
$5.00
|
|
|
Lilly Concerned about IP Protection in China
|
$5.00
|
|
|
China Plans $1.7 Trillion Investment in Hi-Tech, including Biotechnology
|
$5.00
|
|
|
Tasly Pharma Selects ICON for Global Phase III Trial of TCM Heart Drug
|
$5.00
|
|
|
BGI Forms Children’s Disease Partnership with Philadelphia Hospital
|
$5.00
|
|
|
SFDA Will Inspect Foreign Drug Makers
|
$5.00
|
|
|
Novartis Will Invest $25 Million in Zhongshan Facility
|
$5.00
|
|
|
Italian Pharma Menarini Buys Invida of Singapore
|
$5.00
|
|
|
Tiantan Biological Receives $24 Million from Gates Foundation
|
$5.00
|
|
|
Pfizer’s Shanghai Anti-Infectives Research Unit Delayed
|
$5.00
|
|
|
Lepu Medical Buys Controlling Interest in Dutch Device Maker
|
$5.00
|
|
|
Hutchison MediPharma Starts Clinical Trial of Cancer Drug
|
$5.00
|
|
|
WuXi PharmaTech to Form $50 Million Venture Fund
|
$5.00
|
|
|
Fosun Pharma Buys 6.5% Stake in Simcere for $30 Million
|
$5.00
|
|
|
China Resources Medications Forms $158 Million JV with Pientzehuang
|
$5.00
|
|
|
Former Head of Shanghai Pharma Given Death Sentence for Accepting Bribes
|
$5.00
|
|
|
Sinovac Biotech’s EV71 Vaccine Passes Phase II Test
|
$5.00
|
|
|
Kunming Pharma will Raise $110 Million to Boost Capacity
|
$5.00
|
|
|
China Biotech’s Hong Kong IPO to Raise Up to $2 Billion
|
$5.00
|
|
|
Jennerex/Lee’s Pharma Report Positive Phase II Data for Cancer Drug
|
$5.00
|
|
|
Yabao Pharma Raises $74 Million in Secondary Offering
|
$5.00
|
|
|
Sanofi Says China Sales Grew 47% to $370 Million in Q3
|
$5.00
|
|
|
China National Biotechnology to IPO on the Hong Kong Exchange
|
$5.00
|
|
|
ImmBio Strikes China Deal with CNBG Unit for TB Vaccine
|
$5.00
|
|
|
Aslan Pharma In-licenses China Rights to BMS Cancer Drug
|
$5.00
|
|
|
Novo Nordisk Rejects China M&A; Will Grow through Innovation
|
$5.00
|
|
|
The FDA Improves Tracking of Foreign-Sourced Drugs
|
$5.00
|
|
|
Healthgen, a China Startup, Announces Rice-Derived Human Serum Albumin
|
$5.00
|
|
|
Alios Signs Flu Treatment Deal with Univ. of Hong Kong
|
$5.00
|
|
|
Gates Foundation and China Form $300 Million Drug and Agriculture Partnership
|
$5.00
|
|
|
China to Up Vaccine Protection against Epidemics
|
$5.00
|
|
|
Lansen Pharma In-licenses China Rights to Rheumatoid Drug
|
$5.00
|
|
|
Lepu Medical Invests $15.6 Million to Increase Medical Device Capacity
|
$5.00
|
|
|
Novartis Transferring Jobs from Europe/US to China and India
|
$5.00
|
|
|
Modern Hasen Pharma Building $43.6 Million Essential Drug Facility
|
$5.00
|
|
|
BioBay, Roche and Harvard Form Novel Cancer Drug Partnership
|
$5.00
|
|
|
WuXi PharmaTech Makes Clinical-Stage CRO Acquisition
|
$5.00
|
|
|
ShangPharma Buys Charles River’s Shanghai Lab
|
$5.00
|
|
|
Simcere Partners Up with Suzhou NeuPharma on Cancer Drug
|
$5.00
|
|
|
Medicilon to Complete Pre-Clinical Work on South Korean Anti-Depressant
|
$5.00
|
|
|
Hepalink Pharma Posts Lower Q3 Results
|
$5.00
|
|
|
Zhuhai Hokai Medical Instruments Completes ChiNext IPO
|
$5.00
|
|
|
Lundbeck Sets Up Research Center in Shanghai
|
$5.00
|
|
|
Sinocom Pharma Withdraws Nasdaq IPO
|
$5.00
|
|
|
WuXi Buys Abgent, a US-China Antibody Maker
|
$5.00
|
|
|
BeiGene In-Licenses Two Potential Cancer Drugs from Janssen
|
$5.00
|
|
|
ViroMed’s Gene Therapy Drug Given SFDA Approval for Phase II Trial
|
$5.00
|
|
|
Sinovac Lands Flu Vaccine Order from Beijing CDC
|
$5.00
|
|
|
SemBioSys Genetics of Canada Forms JV with Tasly Pharma
|
$5.00
|
|
|
Chiva Pharma Acquires Global Rights to Osteoporosis Drug from Ligand
|
$5.00
|
|
|
Biostar Announces $9.6 Million China Acquisition
|
$5.00
|
|
|
University of Hong Kong and Sinopharm Sign Cooperation Agreement
|
$5.00
|
|
|
AstraZeneca to Build $200 Million Manufacturing Plant in China Medical City
|
$5.00
|
|
|
China Attacks Antibiotic Overuse, Putting Pressure on Makers’ Stock Prices
|
$5.00
|
|
|
India Takes Aim at China Pharma's Inroads into the Indian Market
|
$5.00
|
|
|
SciClone Announces $20 Million Stock Buyback
|
$5.00
|
|
|
GSK Seeking Up to $2B Bolt-on Acquisitions in India
|
$5.00
|
|
|
Guizhou Bailing Buys Another Ethnic-Miao TCM Company
|
$5.00
|
|
|
Nycomed/Takeda Adds Antihistamine to China Portfolio
|
$5.00
|
|
|
China’s Pharma Output Climbed 30% in First Seven Months of 2011
|
$5.00
|
|
|
Sanjiu Medical Buys Four Small Pharmas
|
$5.00
|
|
|
Merck Names China Expert as Directory of Strategy
|
$5.00
|
|
|
Newsummit Launches $100 Million Fund for US Medical Device Makers
|
$5.00
|
|
|
Cardinal Health Seeking to Acquire China Drug Distributors
|
$5.00
|
|
|
Sinovac Given Final Go-Ahead for Animal Rabies Vaccine
|
$5.00
|
|
|
Zhongsheng Pharma Commits $3 Million to Three Novel Drugs
|
$5.00
|
|
|
AstraZeneca Remains Committed to Partnering in China
|
$5.00
|
|
|
China Grand Pharma Pays $17 Million for Wuhan Kernel Biotech
|
$5.00
|
|
|
ProMetic Sells Biotech Product in China
|
$5.00
|
|
|
Daiichi Sankyo Given OK for Prostatic Hyperplasia Drug in China
|
$5.00
|
|
|
Cipla, with Plants in China and India, Goes After Biosimilar Market
|
$5.00
|
|
|
Lingrui Pharma Raises $60 Million to Expand Capacity
|
$5.00
|
|
|
Pfizer Signs Jointown to Distribute its Drugs in China
|
$5.00
|
|
|
Avenue Capital Plans $313 Million Fund for China Medical City
|
$5.00
|
|
|
China Scientist Given Lasker Award for TCM-based Malaria Drug
|
$5.00
|
|
|
Covidien to Build Medical Device R&D Center in Shanghai
|
$5.00
|
|
|
ShangPharma Forms mAb Partnership with Hengrui Medicine
|
$5.00
|
|
|
Merck Serono and Pharmaron Partner in Beijing Lab
|
$5.00
|
|
|
China’s Push for Low Prices Causes Drug Shortages
|
$5.00
|
|
|
Merck Partners with China’s BGI on Genomics
|
$5.00
|
|
|
HealthLinx and CytogenDx to Develop New Ovarian Cancer IVD for China
|
$5.00
|
|
|
Pfizer Starts Animal Health JV with Jilin Guoyuan
|
$5.00
|
|
|
Fosun Pharma Buys 70% of Jinzhou Ahon Pharma fo $219 Million
|
$5.00
|
|
|
Four China Vitamin C Makers to Face Price Fixing Charges in US
|
$5.00
|
|
|
Fosun Pharma and Lonza to Start Generic Drug JV
|
$5.00
|
|
|
AllCells Expands Primary Cell Services in Shanghai
|
$5.00
|
|
|
GlaxoSmithKline to Use Three Vaccine Distributors to Cover China
|
$5.00
|
|
|
SinoCubate Signs on Biotech Startup Veteran for Incubator
|
$5.00
|
|
|
Merck Serono Opens Beijing Lab
|
$5.00
|
|
|
Royal DSM and Sinochem Close Antibiotics JV Deal
|
$5.00
|
|
|
NexBio Reports Positive Data from Test of Biologic Flu Drug
|
$5.00
|
|
|
Nycomed Says Growth in China Helped Revenues
|
$5.00
|
|
|
Sinopharm Beats Estimates for First Half of 2011
|
$5.00
|
|
|
China’s Government Spent $39 Billion on Healthcare in 1H of 2011
|
$5.00
|
|
|
SFDA Issues Anti-Counterfeiting Rules for CMOs
|
$5.00
|
|
|
Simcere Obtains SFDA Approval for Rheumatoid Arthritis Treatment
|
$5.00
|
|
|
Vasomedical Buys Two China Medical Device Manufacturers
|
$5.00
|
|
|
WuXi AppTec Certified by European Authorities for Bioanalytical Services
|
$5.00
|
|
|
Simcere Passes EU-GMP Inspection for OTC Diarrhea Treatment
|
$5.00
|
|
|
Life Technologies’ Q2 Hurt by Revamping of China Sales Strategy
|
$5.00
|
|
|
Asymchem Announces $39 Million in VC Funds
|
$5.00
|
|
|
Shanghai Pharma Acquires Jiangsu Drug Distributor
|
$5.00
|
|
|
Epitomics Plans Taiwan IPO Later in 2011
|
$5.00
|
|
|
WuXi PharmaTech to Add Clinical Trial CRO Services
|
$5.00
|
|
|
3SBio Forms Investment Partnership with China Medical City
|
$5.00
|
|
|
Shanghai Pharma Wants to Acquire US or European Pharma
|
$5.00
|
|
|
Sinopharm Acquires Wuhan Zhongliang Pharma
|
$5.00
|
|
|
Beijing SL Pharma Forms Canadian Vaccine JV
|
$5.00
|
|
|
New FDA Plan to Increase Foreign Drugmaker Inspections
|
$5.00
|
|
|
ShangPharma Bumps Stock Price 28% Higher with Share Buyback
|
$5.00
|
|
|
WuXi PharmaTech Reports Big Jump in Q2 Manufacturing Revenues
|
$5.00
|
|
|
ShangPharma Touts Growth in its Biologics Division
|
$5.00
|
|
|
Bohai Pharma Acquires Yantai Tianzheng Pharma, a TCM Maker
|
$5.00
|
|
|
NDRC Mandates Price Cuts on 82 Drugs
|
$5.00
|
|
|
Mingyuan Medicare Buys Diagnostic Company for $55 Million
|
$5.00
|
|
|
China Medical Technology and Leica to Form IVD Collaboration
|
$5.00
|
|
|
Changshan Biochemical Sets Price for ChiNext IPO
|
$5.00
|
|
|
Hisun Pharma Makes Another US Investment; This One with PharmTek
|
$5.00
|
|
|
Global Pharm Acquires Drug Distributor for $9 Million
|
$5.00
|
|
|
VWR Buys China’s LabPartner, a Fellow Lab Products Supplier
|
$5.00
|
|
|
Simcere Plans to Triple Headcount in New R&D Facility
|
$5.00
|
|
|
BGI and GT Life Sciences Publish Chinese Hamster Ovary Genome
|
$5.00
|
|
|
Shionogi of Japan to Take Control of China’s C&O Pharma
|
$5.00
|
|
|
Merck Reduces Workforce Globally while Building in China
|
$5.00
|
|
|
Shanxi C&Y Pharma to IPO on the ChiNext Exchange
|
$5.00
|
|
|
Hepalink Pharma’s Shares Fall on Lower Profit
|
$5.00
|
|
|
Yiling Pharma Climbs in Post-IPO Trading
|
$5.00
|
|
|
Boston Scientific to Spend $150 Million in China
|
$5.00
|
|
|
Meheco Signs Contract for Controlling Interest in Tianshan
|
$5.00
|
|
|
BGI Work on Structural Variations Published in Journal
|
$5.00
|
|
|
Aeras and China National Biotech Sign MOU for TB Vaccine
|
$5.00
|
|
|
Chi-Med Forming an OTC Drug Distribution JV
|
$5.00
|
|
|
Merck and Simcere Form China JV to Develop and Sell Branded Drugs
|
$5.00
|
|
|
Ascletis Adds Support to $100 Million in Startup Capital
|
$5.00
|
|
|
Biolight Meditech and D.A. Diagnostics Debut on ChiNext Exchange
|
$5.00
|
|
|
Shijiazhuang Yiling Pharma Raises Offering Price of ChiNext IPO
|
$5.00
|
|
|
Sihuan Pharma Sells 50% of Drug Distribution Subsidiary to Shandong Buchang
|
$5.00
|
|
|
Chongqing Zhifei Nixes Plan to Buy Bilthoven Biologicals
|
$5.00
|
|
|
BeiLu Pharma Gives Up on Melatonin-based Depression Drug
|
$5.00
|
|
|
China Takes Dramatic Step to Curb TCM Speculation
|
$5.00
|
|
|
Bristol-Myers Squibb Ups its Plans for China
|
$5.00
|
|
|
China Leads India on Drug Patents and Academic Drug Research
|
$5.00
|
|
|
Guizhou Bailing Buys Majority Stake in Guizhou Herentang
|
$5.00
|
|
|
Shanghai Pharma Spending to Build Drug Distribution Business
|
$5.00
|
|
|
Novartis May IPO in China
|
$5.00
|
|
|
3SBio Given OK for High-Dose EPIAO
|
$5.00
|
|
|
Sagent Pharma Adds Lummy Pharma to its List of China Collaborators
|
$5.00
|
|
|
Hikma Pharma Buys Stake in Hubei Haosun Pharma
|
$5.00
|
|
|
Bimeda Sets Up Veterinary JV with Rainbow Labs
|
$5.00
|
|
|
BeiGene Plans a $100 Million to $150 Million Capital Raise
|
$5.00
|
|
|
Guangzhou Biotech Island Holds Official Opening
|
$5.00
|
|
|
Baotou Dongbao and Grandhope Biotech Soar after ChiNext IPOs
|
$5.00
|
|
|
Baiyunshan Pharma Expands Production Facility
|
$5.00
|
|
|
MingSight and Relin Medicine Form China Ophthalmology JV
|
$5.00
|
|
|
China May Subject HIV/AIDS Treatments to Mandatory Licensing
|
$5.00
|
|
|
Mindray Medical Buys Majority Stake in Urinalysis Company
|
$5.00
|
|
|
ARC Capital Invests $13 Million in Buchang Pharma Group
|
$5.00
|
|
|
Boston Therapeutics and Advance Pharma in China Deal for Glucose Product
|
$5.00
|
|
|
Gloria Pharma Loses Out on Bid to Acquire Dilong Pharma
|
$5.00
|
|
|
Jointown Pharma and 360buy.com to Form Online China Pharmacy
|
$5.00
|
|
|
MedicaNova and Zhejiang Medicine Announce Asthma-focused JV
|
$5.00
|
|
|
Wuhan Kindstar Diagnostics Raises $11 Million in Series B Funding
|
$5.00
|
|
|
Walvax Will Spend $112 Million to Up Vaccine Capacity
|
$5.00
|
|
|
Biotech a Priority in China’s $309 Billion Five-Year Plan
|
$5.00
|
|
|
Sinovac Starts Phase II Trial of EV71 Vaccine
|
$5.00
|
|
|
Microbix and Hunan Influenza JV Looking Doubtful
|
$5.00
|
|
|
Medivir Licenses China Rights for Cold Sore Treatment to Daewoong
|
$5.00
|
|
|
J&J Opens Innovation Center for Medical Devices in Suzhou
|
$5.00
|
|
|
Sirnaomics Names China Partner for siRNA Therapeutic
|
$5.00
|
|
|
Sihuan Pharma Acquires TCM Cardiovascular Drug Maker for $120 Million
|
$5.00
|
|
|
Shandong Jincheng Pharma Completes $72 Million IPO
|
$5.00
|
|
|
China Medical Technology Signs Diagnostic Test Partnership
|
$5.00
|
|
|
Britain and China Announce $155 Million Drug Development Partnership
|
$5.00
|
|
|
BGI and Shenzhen Set Up National Gene Bank
|
$5.00
|
|
|
Biomatters Partners with Genewiz; Plans Entry into China
|
$5.00
|
|
|
SFDA Orders China Recall of GlaxoSmithKline Antibiotic
|
$5.00
|
|
|
CRO ClinTec Making Push into China and Asia Pacific Region
|
$5.00
|
|
|
Rhei Pharma Gaining on SFDA Approval of MuGard™
|
$5.00
|
|
|
PKU Southwest Synthetic Pharma to Acquire 100% of Distribution Subsidiary
|
$5.00
|
|
|
LabCorp Buys Clearstone Labs, Giving it Access to China
|
$5.00
|
|
|
Nycomed to Market Roche Osteoporosis Drug in China and Asia-Pacific
|
$5.00
|
|
|
GlaxoSmithKline to Buy Out China Vaccine JV Partner
|
$5.00
|
|
|
Conba Pharma Forms Cancer JV with Kite Pharma, a US Startup
|
$5.00
|
|
|
Unigene Ends China Peptide JV; Will Out-License Technology
|
$5.00
|
|
|
Luoxin Pharmacy to Develop Narrow-Spectrum Antibiotic
|
$5.00
|
|
|
NDAs and INDs Quantify the Innovation in China’s Drug R&D
|
$5.00
|
|
|
Harbor BioSciences in Deal for ex-China Distribution of Sinopharm Generics
|
$5.00
|
|
|
BGI and U. of California, Davis Announce Partnership
|
$5.00
|
|
|
Selected Value Therapeutics Acquires China Rights to Cancer Drug
|
$5.00
|
|
|
Agenix Discloses Plans for Clinical Trial of Hepatitis B Drug
|
$5.00
|
|
|
Simcere Receives Settlement for Shuttered Rabies Vaccine Facility
|
$5.00
|
|
|
Northeast Pharma Announces $370 million Private Placement
|
$5.00
|
|
|
China Medical System Buys 51% of Drug Maker
|
$5.00
|
|
|
Foci Pharma Seeks EU Approval of TCM
|
$5.00
|
|
|
KingMed Diagnostics Strikes Second Opinions Deal with U. of Pennsylvania
|
$5.00
|
|
|
Zhejiang Huahai Obtains FDA Approval for Alzheimer’s Drug
|
$5.00
|
|
|
Tasly Pharma to Make $40 Million Investment in US Facility
|
$5.00
|
|
|
Pfizer and Zhejiang Hisun Sign MOU for Branded Generics JV
|
$5.00
|
|
|
First China Pharma Progressing on Acquisition of Drug Distributor
|
$5.00
|
|
|
Livzon Pharma to Spend $154 Million on New API Facilities
|
$5.00
|
|
|
All 11 Defendants Plead Guilty in Fake Avastin Case
|
$5.00
|
|
|
D-Pharm Out-licenses China Rights for Epilepsy Drug to Nhwa Pharma
|
$5.00
|
|
|
CAS and Univ. of Pennsylvania Set up Brain Mapping Center
|
$5.00
|
|
|
Sinocom Releases Q1 Report before its IPO
|
$5.00
|
|
|
Sinovac Announces Success for Phase I Trial of EV71 Vaccine
|
$5.00
|
|
|
BeiGene Makes Key Hires in Clinical Research and Regulatory Affairs
|
$5.00
|
|
|
Hainan Honz Pharma’s Main Product Faces Partial SFDA Ban
|
$5.00
|
|
|
Q1 Earnings Review: Healthy Revenue Increases, Smaller Profit Growth
|
$5.00
|
|
|
ShangPharma Reports 26% Increase in Q1 Revenues
|
$5.00
|
|
|
Qiming Shows China Venture Capital Running Strong
|
$5.00
|
|
|
Shanghai Pharma Affiliate Hit with Allegations of Poor Quality
|
$5.00
|
|
|
Walvax “Ends Negotiations” with GlaxoSmithKline
|
$5.00
|
|
|
Takeda Taking Steps for 10-Fold Increase in China Revenues
|
$5.00
|
|
|
Shanghai Pharma Prices Hong Kong IPO at $2 Billion
|
$5.00
|
|
|
Naviscan Signs Up Chindex as China Distributor of Breast-PET Scanner
|
$5.00
|
|
|
Chongqing Zhifei Bidding to Buy Dutch Vaccine Company
|
$5.00
|
|
|
Tianyin Pharma Approved to Launch Diabetes Treatment
|
$5.00
|
|
|
Sanofi Expects China to be its Number Two Market by 2015
|
$5.00
|
|
|
ChChina Stresses Consolidation in Five-Year Plan for Drug Distribution
|
$5.00
|
|
|
China Meheco to Sell $939 Million of Drugs to Venezuela
|
$5.00
|
|
|
WuXi Beats Financial Estimates in Q1
|
$5.00
|
|
|
AstraZeneca’s Phase III Trial of Brilinta Shows a Problem with Going Global
|
$5.00
|
|
|
Sinopharm Xinjiang Unloads Seven Non-operating Subsidiaries
|
$5.00
|
|
|
Simcere Subsidiary Given SFDA Approval for anti-TNF Biosimilar
|
$5.00
|
|
|
Sinocom Pharma Plans $58 Million IPO on Nasdaq
|
$5.00
|
|
|
Crown BioScience Raises $28.8 Million in C Round
|
$5.00
|
|
|
C3 Jian to Form Clinical Research Facility with Sichuan Univ.
|
$5.00
|
|
|
Beijing Second Pharma Wins US Approval for Anti- Hypertensive
|
$5.00
|
|
|
Pfizer to Take Stake in $2.2 Billion Shanghai Pharma IPO
|
$5.00
|
|
|
Shenzhen Edan Instruments Stages $146 Million ChiNext IPO
|
$5.00
|
|
|
Columbia University Licenses Autoimmune IP to China Group
|
$5.00
|
|
|
Roche Expects China to be #3 Market by 2015
|
$5.00
|
|
|
Aslan Pharma of Singapore Raises $12 Million for In-licensing
|
$5.00
|
|
|
Mitsui Gains Interest in Shenzhen Main Luck Pharma
|
$5.00
|
|
|
Shanghai Pharma Reports Earnings Doubled in Q1
|
$5.00
|
|
|
Sinopharm Will Raise $440 Million to Build Distribution Network
|
$5.00
|
|
|
Cash-strapped Lotus Pharma Explains CapEx Decisions
|
$5.00
|
|
|
Neuralstem and BaYi Brain Hospital Plan Stem Cell Trial in Stroke Patients
|
$5.00
|
|
|
Shanghai Pharma and Pfizer Sign MOU to Expand Collaboration
|
$5.00
|
|
|
Kinex Licenses China Rights for Cancer Molecule to Hanmi Pharma
|
$5.00
|
|
|
Morningside Invests in Aduro Biotech, a US Cancer Immunotherapy Co.
|
$5.00
|
|
|
SciClone to Acquire NovaMed Pharma for up to $105 Million
|
$5.00
|
|
|
Jiangbo Commits Some of its Large Cash Hoard to buy Drug Distributor
|
$5.00
|
|
|
Roche Expands Shanghai Facility into Third Global Operations Center
|
$5.00
|
|
|
Standard Chemical (Taiwan) and DIA Pharma (Japan) Form China JV
|
$5.00
|
|
|
Cachet Pharma Adds to Capacity of Beijing Drug Logistics Center
|
$5.00
|
|
|
Shanghai Pharma’s Hong Kong IPO Proceeding Down the Regulatory Path
|
$5.00
|
|
|
Greek Pharma Alapis Signs MoU with CSPC Pharma
|
$5.00
|
|
|
Aoxing Pharma: An Exercise in Patience
|
$5.00
|
|
|
India Tops China in Big Pharma-Generic Deals: Merck Signs up with Sun Pharma
|
$5.00
|
|
|
China Regulates Antibiotics to Curb Abuse
|
$5.00
|
|
|
China Life Science 2010: A Giant Leap Forward
|
$5.00
|
|
|
Jilin Aodong Makes $2 Million Initial Investment in Vital Therapies
|
$5.00
|
|
|
Ascletis Raises $100 Million for US-China Startup
|
$5.00
|
|
|
China Medical System Joins PRC’s Drug Distribution Rollup
|
$5.00
|
|
|
China NT Pharma to Raise $275 Million in Hong Kong IPO
|
$5.00
|
|
|
Pfizer and Daiichi Sankyo Team Up in China
|
$5.00
|
|
|
Lilly Sees Big Opportunity in China
|
$5.00
|
|
|
Shanghai Pharma Bumps Size of Hong Kong IPO by 50%
|
$5.00
|
|
|
Huamin Pharma Plans $168 Million Antibiotic Facility
|
$5.00
|
|
|
China YCT Bets Company on Botanical Flu Treatment
|
$5.00
|
|
|
Merck Serono Expects M&A to Build China Sales
|
$5.00
|
|
|
Kang Sheng Bao to Develop Immune System Diagnostic Test for SuperNova
|
$5.00
|
|
|
ICON Ups China Presence and Posits Double-Standard in China Trials
|
$5.00
|
|
|
Merck Expects to Garner 25% of its Revenues in China by 2013
|
$5.00
|
|
|
Latest Round of Cuts in Drug Prices Takes Effect in China
|
$5.00
|
|
|
Zhejiang Hisun Pharma Invests in US Biotech Startup
|
$5.00
|
|
|
China Kanghui Acquires Stake in Orthopedic Implant Company
|
$5.00
|
|
|
Competition between Drug Distributors Heats Up in Zhejiang Province
|
$5.00
|
|
|
Takeda Pharma Ups Commitment to China
|
$5.00
|
|
|
American Oriental Bioengineering: All Dressed Up, Nowhere to Go
|
$5.00
|
|
|
Chongqing Fuan Pharma Makes Its Debut on ChiNext Exchange
|
$5.00
|
|
|
Novartis Will Add China Sales Reps to Gain Market Share
|
$5.00
|
|
|
China Touts Quick Identification of Novel Deadly Pathogen
|
$5.00
|
|
|
Jilin Jian Yisheng Pharma IPOs on Shenzhen Exchange
|
$5.00
|
|
|
SuperNova Diagnostics to Partner with Kang Sheng Bao Bio-Tech
|
$5.00
|
|
|
Novo Nordisk Wins China Approval for Diabetes Drug
|
$5.00
|
|
|
Shenogen Signs Up ShangPharma to Help Develop Cancer Drug
|
$5.00
|
|
|
Pfizer Moving Antibacterial R&D from US to Shanghai
|
$5.00
|
|
|
Pharmaron Signs CMO Contract with Isis Pharma
|
$5.00
|
|
|
First China Pharma Acquires Fellow Drug Distributor
|
$5.00
|
|
|
Four China Vitamin C Producers Charged in US Antitrust Suit
|
$5.00
|
|
|
China Orders More Price Cuts for Drugs
|
$5.00
|
|
|
Mindray Medical Buys China Infusion Pump Maker
|
$5.00
|
|
|
Life Technologies Opens Asia-Pacific Distribution Center
|
$5.00
|
|
